12:00 AM
 | 
Mar 17, 2016
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Adenylate cyclase 5 (AC5)

Cardiovascular disease

INDICATION: Ischemia / reperfusion injury

Mouse and pig studies suggest inhibiting AC5 could help treat ischemia/reperfusion injury. In a mouse model of coronary artery occlusion, heart-specific knockout...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >